Featured Transactions

M&A
Equity
Debt
Restructuring

M&A

  • Gaming
    Jul-2025
    Pending
    €2,700,000,000
    Sale of International Interactive business to Intralot S.A.
    Joint Financial Advisor
  • Healthcare
    Jun-2025
    $9,500,000,000
    Sale to Sanofi
    Joint Financial Advisor
  • Industrials
    Jun-2025
    Pending
    $5,500,000,000
    Sale to The Home Depot
    Sole Financial Advisor
  • Energy
    May-2025
    Pending
    $3,350,000,000
    Acquisition of 60% interest in offshore Brazil assets from Equinor
    Sole Financial Advisor
  • Finance
    May-2025
    Pending
    $8,750,000,000
    Acquisition of The AZEK Company
    Lead Financial Advisor
  • Industrials
    Mar-2025
    $8,750,000,000
    Acquisition of The AZEK Company
    Lead Financial Advisor
  • Consumer
    Mar-2025
    $1,175,000,000
    Sale to Affinity Equity Partners
    Lead Financial Advisor
  • Technology
    Feb-2025
    $4,384,000,000
    Sale to Turn/River Capital
    Joint Financial Advisor
  • Healthcare
    Jan-2025
    $14,630,000,000
    Sale to Johnson & Johnson
    Joint Financial Advisor
Return to Top

Equity

  • Healthcare
    May-2025
    CHF 1,900,000,000
    Common Stock Offering on behalf of
    EQT, ADIA and GIC
    Joint Global Coordinator
  • Finance
    Jun-2025
    $1,442,000,000
    Initial Public Offering
    Joint Bookrunner
  • Finance
    May-2025
    $713,000,000
    Initial Public Offering
    Joint Lead Bookrunner
  • Finance
    May-2025
    $457,000,000
    Initial Public Offering
    Joint Active Bookrunner
  • Healthcare
    Sep-2024
    $1,500,000,000
    Common Stock Offering
    Joint Bookrunner
  • Healthcare
    Jun-2024
    $1,000,000,000
    Private Placement of Equity
    Joint Financial Advisor
  • Energy
    May-2024
    €1,400,000,000
    Common Stock Offering
    Joint Global Coordinator
  • AeroDefense
    Apr-2024
    $354,000,000
    Initial Public Offering
    Lead Left Bookrunner
Return to Top

Debt

  • Technology
    Jun-2023
    $1,050,000,000
    Credit Facility
    Joint Lead Arranger
  • Healthcare
    May-2023
    $1,383,000,000
    Amendment and Extension of Credit Facility
    Joint Lead Arranger
  • Healthcare
    May-2023
    $1,060,000,000
    Credit Facility
    Joint Lead Arranger
  • Finance
    Feb-2023
    $1,170,000,000
    Credit Facility
    Joint Lead Arranger
  • Consumer
    Feb-2023
    $1,132,000,000
    Amendment and Extension of Credit Facility
    Joint Lead Arranger
  • Technology
    Nov-2022
    $3,496,000,000
    Credit Facility to Finance Acquisition of Intertrust N.V.
    Joint Lead Arranger
  • Technology
    Aug-2022
    $1,720,000,000
    Credit Facility to Finance Acquisition by KKR
    Joint Lead Arranger
  • Power
    May-2022
    $1,543,000,000
    Credit Facility
    Sole Lead Arranger
  • Industrials
    Apr-2022
    $3,526,000,000
    Financing for Acquisition of Ferro Corp. and merger with Chromaflo
    Joint Lead Arranger and Joint Bookrunner
Return to Top

Restructuring

  • Telecom
    Mar-2025
    $1,600,000,000
    Restructuring
    Financial Advisor to the Official Committee
    of Unsecured Creditors
  • Healthcare
    Mar-2025
    $910,000,000
    Restructuring
    Joint Financial Advisor
  • Finance
    Jan-2025
    $21,152,000,000
    Reorganization
    Financial Advisor to the Official Committee
    of Unsecured Creditors
  • Industrials
    Jan-2025
    $1,100,000,000
    Recapitalization
    Financial Advisor to the Company
  • Energy
    Dec-2024
    $1,116,000,000
    Recapitalization
    Financial Advisor to the Company
  • AeroDefense
    Aug-2024
    $3,400,000,000
    Reorganization
    Financial Advisor to the Official Committee
    of Unsecured Creditors
  • Healthcare
    Aug-2024
    $4,000,000,000
    Reorganization
    Financial Advisor to the Official Committee
    of Tort Claimants
  • Industrials
    May-2024
    $1,059,000,000
    Restructuring
    Financial Advisor to the Official Committee
    of Unsecured Creditors
  • Healthcare
    Apr-2024
    $8,148,000,000
    Restructuring
    Financial Advisor to the Official Committee
    of Opioid Claimants
Return to Top

Related content

Back to Investment Banking overview